Global Deep Brain Stimulation Systems Market, By Product Type (Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator), Application (Obsessive Compulsive Disorder, Parkinson’s Disease, Essential Tremor, Epilepsy, Dystonia), Type (Rechargeable, Non-Rechargeable), End User (Hospitals, Ambulatory Surgical Centers (ASCs), Neurological Clinic) – Industry Trends and Forecast to 2030.
Deep Brain Stimulation Systems Market Analysis and Size
Deep brain stimulation has proven to be an effective treatment for various neurological disorders, particularly when other therapies or medications are inadequate or cause significant side effects. This efficacy drives both patient and physician interest in DBS systems. Advances in DBS system technology, including more precise and adjustable electrodes, improved stimulation algorithms, and remote monitoring capabilities, make the treatment safer, more effective, and more patient-friendly. These innovations contribute to market growth.
Data Bridge Market Research analyzes that the deep brain stimulation systems market, which was USD 2,646.45 million in 2022, is likely to reach USD 5,273.22 billion by 2030 and is expected to undergo a CAGR of 9.0% during the forecast period. “Single-Channel Deep Brain Stimulator” dominates the product type segment of the deep brain stimulation systems market due to the growing demand for deep brain stimulation systems.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator), Application (Obsessive Compulsive Disorder, Parkinson’s Disease, Essential Tremor, Epilepsy, Dystonia), Type (Rechargeable, Non-Rechargeable), End User (Hospitals, Ambulatory Surgical Centers (ASCs), Neurological Clinic)
|
|
Countries Covered
|
U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America
|
|
Market Players Covered
|
Boston Scientific Corporation (U.S.), Fisher Wallace (U.S.), SceneRay Corporation, Limited (China), Beijing PINS Medical Co., Ltd (China), ALEVA NEUROTHERAPEUTICS SA (Switzerland), MEDTRONIC (Ireland), Abbott (U.S.)
|
|
Market Opportunities
|
|
Market Definition
The deep brain stimulation (DBS) systems market is the industry related to the development, manufacturing, and distribution of medical devices and equipment used in deep brain stimulation therapy. DBS is a neurosurgical procedure that involves the implantation of a medical device known as a neurostimulator or brain pacemaker into specific areas of the brain. This neurostimulator delivers electrical impulses to modulate the abnormal activity of brain circuits and alleviate symptoms of various neurological and psychiatric disorders.
Global Deep Brain Stimulation Systems Market Dynamics
Drivers
- Rising technological advancements
Advances in DBS system technology, including more precise and adjustable electrodes, improved stimulation algorithms, and remote monitoring capabilities, make the treatment safer, more effective, and more patient-friendly. These innovations contribute to market growth. Advancements in DBS technology have led to more precise and targeted stimulation of specific brain areas. This precision minimizes side effects and maximizes therapeutic outcomes, making DBS an even more attractive treatment option.
- Supportive reimbursement policies
In many regions, healthcare systems and insurance providers have implemented supportive reimbursement policies for DBS procedures, making them more accessible and affordable for patients. Supportive reimbursement policies reduce the financial burden on patients seeking DBS therapy. When insurance providers or government healthcare programs cover a significant portion of the costs, more patients can afford and access this treatment, leading to increased demand.
Opportunity
- Rise in demand for minimal invasive surgery
Many patients prefer minimally invasive surgical options due to the potential for quicker recovery, reduced scarring, and less post-operative pain. This preference can drive interest in minimally invasive DBS procedures, leading to increased adoption. As the demand for minimally invasive surgical techniques increases, the development of minimally invasive DBS procedures becomes more important. Minimally invasive DBS surgery involves smaller incisions, less tissue disruption, and shorter recovery times, making it an attractive option for patients.
Restraints/Challenges
- Lack of awareness
There is a lack of awareness about DBS therapy among the general public, as well as some healthcare providers. Patients may not be informed about DBS as a potential treatment option, and healthcare providers may not be well-versed in the latest advancements in DBS technology.
Recent Development
- FDA approved deep brain stimulation device Percept by Medtronic in June’2020. The company uses BrainSense technology for chronically capturing and recording brain signals to patients with neurological disorders
- February 2019 - Deep Brain Stimulation (DBS) has been made available in the United States by Medtronic for those with medically intractable epilepsy. This innovative product introduction will help the business increase both its consumer base and its income
- January 2020 - The internal globus pallidus was added as a target for Abbott's Infinity Deep Brain Stimulation (DBS) device
Global Deep Brain Stimulation Systems Market Scope
The deep brain stimulation systems market is segmented on the basis of product type, application, type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Single-Channel Deep Brain Stimulator
- Dual-Channel Deep Brain Stimulator
Application
- Obsessive Compulsive Disorder
- Parkinson’s Disease
- Essential Tremor
- Epilepsy
- Dystonia
Type
- Rechargeable
- Non-Rechargeable
End User
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Neurological Clinic
Global Deep Brain Stimulation Systems Market Regional Analysis/Insights
The deep brain stimulation systems market is analyzed and market size insights and trends are provided by country, product type, application, type, and end user as referenced above.
The countries covered in the deep brain stimulation systems market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.
North America is expected to dominate the market due to the presence of advanced healthcare infrastructure.
Asia-Pacific is expected to grow during the forecast period due to surge in regional investments.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The deep brain stimulation systems market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the deep brain stimulation systems market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the Deep brain stimulation systems market.
Competitive Landscape and Deep Brain Stimulation Systems Market Share Analysis
The deep brain stimulation systems market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the Deep brain stimulation systems market.
Some of the major players operating in the deep brain stimulation systems market are:
- Boston Scientific Corporation (U.S.)
- Fisher Wallace (U.S.)
- SceneRay Corporation, Limited (China)
- Beijing PINS Medical Co., Ltd (China)
- ALEVA NEUROTHERAPEUTICS SA (Switzerland)
- MEDTRONIC (Ireland)
- Abbott (U.S.)
SKU-